Comparing Strategies for Critical Congenital Heart Disease Newborn Screening.

OBJECTIVES An extended newborn critical congenital heart disease (CCHD) screening program using oximetry has been implemented in Taipei, Taiwan since April 2014. This study was conducted to investigate the test accuracy and efficiency of this screening protocol. METHODS This study analyzed data from 30 birthing facilities representing 87.9% of live births in Taipei. Positive screening was defined as oxygen saturation <95% in either extremity or a preductal-postductal oxygen saturation difference of >3%. This study cohort was used to retrospectively estimate outcomes on the basis of different CCHD screening protocols. RESULTS During the study period, 93 058 of 94 239 (98.7%) infants who had no prenatal suspicion were screened. The referral rate was 0.17% (156/93 058), and up to 90% of test-positive infants were referred within 48 hours of life. Forty-two CCHD cases without prenatal suspicion were detected and 97.6% were diagnosed within 72 hours of life. Of the screened newborns, 4 CCHD cases passed the screening. The false positive and false negative rates were 0.12% and 0.04%, respectively. In addition, applying our database to Spanish and updated American Academy of Pediatrics screening strategies led to more CCHD case detection. CONCLUSIONS The Taipei protocol provided an efficient and effective screening referral system in a community setting. For optimal efficiency, we advocated the updated American Academy of Pediatrics algorithm/Spanish recommendation with a modification of immediate referral if oxygen saturation ≤90% in either extremity. The updated protocol would be practicable for nationwide screening in Taiwan and could also be applied to other regions with similar medical care systems.

[1]  Y. Singh,et al.  Impact of pulse oximetry screening to detect congenital heart defects: 5 years’ experience in a UK regional neonatal unit , 2021, European Journal of Pediatrics.

[2]  B. Schwartz,et al.  Newborn Pulse Oximetry Screening at a Community Hospital: An 8-Year Experience , 2021, Pediatrics.

[3]  C. Sable,et al.  Pulse Oximetry and Congenital Heart Disease Screening: Results of the First Pilot Study in Morocco , 2020, International journal of neonatal screening.

[4]  A. Kemper,et al.  Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease , 2020, Pediatrics.

[5]  F. Bloomfield,et al.  introduce nationwide pulse oximetry screening for the detection of critical congenital heart disease and other hypoxaemic conditions in the newborn. , 2020, The New Zealand medical journal.

[6]  N. Blom,et al.  Accuracy of Pulse Oximetry Screening for Critical Congenital Heart Defects after Home Birth and Early Postnatal Discharge , 2018, The Journal of pediatrics.

[7]  T. Orlikowsky,et al.  Pulse Oximetry Screening in Germany—Historical Aspects and Future Perspectives , 2018, International journal of neonatal screening.

[8]  M. Luna,et al.  Pulse oximetry screening of critical congenital heart defects in the neonatal period. The Spanish National Neonatal Society recommendation , 2017 .

[9]  W. Walsh,et al.  A Single-Extremity Staged Approach for Critical Congenital Heart Disease Screening: Results from Tennessee , 2017 .

[10]  M. Ye,et al.  Pulse Oximetry and Auscultation for Congenital Heart Disease Detection , 2017, Pediatrics.

[11]  A. Kosinski,et al.  Congenital Heart Disease in Premature Infants 25‐32 Weeks' Gestational Age , 2017, The Journal of pediatrics.

[12]  A. Ewer,et al.  Newborn Pulse Oximetry Screening: Which Algorithm Is Best? , 2016, Pediatrics.

[13]  Julia C Phillippi,et al.  Lessons Learned From Newborn Screening for Critical Congenital Heart Defects , 2016, Pediatrics.

[14]  K. Hsiao,et al.  Development of a Newborn Screening Program for Critical Congenital Heart Disease (CCHD) in Taipei , 2016, PloS one.

[15]  M. Thong,et al.  Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country , 2015, PloS one.

[16]  Guo-ying Huang,et al.  Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study , 2014, The Lancet.

[17]  T. Ojala,et al.  Nordic pulse oximetry screening – implementation status and proposal for uniform guidelines , 2014, Acta paediatrica.

[18]  A. Ewer,et al.  The impact of routine predischarge pulse oximetry screening in a regional neonatal unit , 2014, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[19]  A. Kemper,et al.  Results From the New Jersey Statewide Critical Congenital Heart Defects Screening Program , 2013, Pediatrics.

[20]  A. Ewer Review of pulse oximetry screening for critical congenital heart defects in newborn infants , 2013, Current opinion in cardiology.

[21]  D. Chui,et al.  Pulse oximetry screening for critical congenital heart defects , 2012, The Lancet.

[22]  J. Zamora,et al.  Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis , 2012, The Lancet.

[23]  J. Towbin,et al.  Endorsement of Health and Human Services Recommendation for Pulse Oximetry Screening for Critical Congenital Heart Disease , 2012, Pediatrics.

[24]  W. Kawalec,et al.  Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: experience of the POLKARD pulse oximetry programme 2006-2008 in Poland. , 2012, Kardiologia polska.

[25]  G. Pearson,et al.  Strategies for Implementing Screening for Critical Congenital Heart Disease , 2011, Pediatrics.

[26]  J. Deeks,et al.  Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study , 2011, The Lancet.

[27]  K. Sandberg,et al.  Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39 821 newborns , 2009, BMJ : British Medical Journal.